Lower-Dose Leuprolide Agent Earns FDA Nod for Advanced PC – Medscape

Written by

admin

in

  1. Lower-Dose Leuprolide Agent Earns FDA Nod for Advanced PC  Medscape
  2. FDA OKs Leuprolide Mesylate 3-Month Formulation in Advanced Prostate Cancer  CancerNetwork
  3. FDA Approved Camcevi ETM New Drug Application for Prostate Cancer  Curetoday
  4. Foresee Pharmaceuticals Announces FDA Approval of CAMCEVI ETM for the Treatment of Advanced Prostate Cancer  Yahoo Finance
  5. FDA Approves 3-Month Leuprolide Mesylate 21 mg Formulation for Advanced Prostate Cancer  Pharmacy Times

Continue Reading

More posts